Posts by Zoe Dunn

Why Pharma Refuses to See Value in “Influence”

Why Pharma Refuses to See Value in “Influence”

All pharma marketers know how to use digital channels to best reach their audiences, right? And they know when to use social media for strategic impact. And of course they know the value of search engine optimization, and how to distinguish it from search engine marketing. OK, maybe not. But...

Drugmakers: Take a Note From P&G, and Generate Some Goodwill

Drugmakers: Take a Note From P&G, and Generate Some Goodwill

Not too long ago, at Digital Pharma East in Philadelphia, an amazing idea dawned on me. This happened in the wake of several presentations, including a no-holds-barred, how-did-we-let-it-get-this-bad, in-your-face exploration of recent PR industry blunders (read: Valeant, Turing, and Mylan) by Heartbeat Ideas’ Bill Drummy. Public opinion of the pharma...

Hale Advisors - 5 questions raised at the fdas off-label hearing

5 questions raised at the FDA’s off-label hearing

One physician believes that changing regulations to allow off-label communications would mean there is less of an incentive for drugmakers to take their therapies through the FDA approval process. That view and others were shared Wednesday at the first day of the FDA’s public hearing to solicit input from pharma...

1 2 3 4 25